GovChime
UEI: PAN3ZK2YLAL2 • CAGE: 969E2

AURAVAX THERAPEUTICS, INC. (TX)

Registration and award facts

SAM.gov registration as of

Net obligations since FY2024
$750K
$749,999under this UEI
FY2026 obligations
$0
Provisional
Awards and orders
1
with positive net obligations
Latest action
Sep 30, 2026
SAM.gov registration
Active
Registration expiration date Jan 21, 2027

Registration

Entity structure
Corporate Entity (Not Tax Exempt)
Business start date
Aug 14, 2020 (6 years)
Location
Houston, TX
State of incorporation
Delaware

† FY2026 obligations (provisional; DoD awards signed after Jul 25, 2026 are not yet public).

Source: SAM.gov entity registration and FPDS contract actions recorded under UEI PAN3ZK2YLAL2. GovChime does not check exclusions.

Performance

Net obligations recorded under this UEI since FY2024. Top lists show the largest five by share of this vendor's net obligations; the shares do not sum to 100%.

Net obligations by fiscal year of action

  • FY2024: $749,999

Total across 1 fiscal year: $749,999

Top awarding agencies

Top awarding sub-agencies

Top NAICS by obligations

Top product and service codes by obligations

  • AN14Health r&d services; health care services; r&d administrative expenses$749,999, 100%

Capabilities

NAICS codes

Small: small business for that NAICS, self-certified in SAM.gov registration.

SBA certifications

No certification in the SBA profile data.

Business types self-reported in SAM.gov registration:

  • Self Certified Small Disadvantaged Business

Product and service codes (PSC)

  • 6505Other Services/Supplies

Contracts

Latest awards and orders

  1. 75A50124C00054Definitive contractDepartment of Health and Human ServicesAdministration for Strategic Preparedness and ResponseLatest action

Contact Info

As of . Source: SAM.gov Points of Contact.

SAM.gov registration for AURAVAX THERAPEUTICS, INC. lists a physical address and a separate mailing address, along with 5 verified points of contact. Past Performance contacts are the recommended outreach channel for due-diligence references; Government Business contacts handle procurement-facing correspondence.

Source: SAM.gov entity registration. Contacts displaying numeric or placeholder names have been filtered (defense-in-depth).

Physical Address

807 WENDEL STREET

HOUSTON, TX, 77009

USA

Mailing Address

807 WENDEL STREET

HOUSTON, TX, 77009

USA

Government Business Contact

JOSEPH SULLIIVAN

CEO

807 WENDELL STREET

HOUSTON, TX, 77009

USA

Electronic Business Contact

Joseph Sulliivan

CEO

807 Wendell Street

Houston, TX, 77009

USA

Past Performance Contact

LAURENCE COOPER

BOARD CHAIR

807 WENDELL STREET

HOUSTON, TX, 77009

USA

Government Business Alternate Contact

JOSEPH SULLIIVAN

CEO

807 WENDELL STREET

HOUSTON, TX, 77009

USA

Electronic Business Alternate Contact

EDEN COOPER

PRESIDENT

807 WENDELL STREET

HOUSTON, TX, 77009

USA

Additional Details

As of . Source: SAM.gov Entity Registration.

AURAVAX THERAPEUTICS, INC. has no active federal suspension or debarment on record in SAM.gov. Current SAM.gov registration expires January 21, 2027.

Source: SAM.gov entity registration (FAR responses, registration status). Always verify active exclusions against the authoritative record on SAM.gov before contract award.

Compliance & Risk Assessment

Source: SAM.gov FAR responses

Suspension/Debarment Status

SAM.gov registration reports no active exclusion

Public Display

Entity information is publicly displayed

Disaster Relief Registry

Not registered for disaster relief

Bonding Information

No bonding information provided

EDI

Not declared in SAM.gov

Business Structure

Source: SAM.gov
Profit Structure:For Profit Organization

Registration Details

Source: SAM.gov

Initial Registration

Oct 1, 2021

Last Update

Jan 23, 2026

Registration Activation

Active — Jan 23, 2026

Fiscal Year End

1231

Country of Incorporation

USA

Congressional District

18